Published :
Tables : 56
Figures : 51
Category : Healthcare
No. of Pages : 243
Report Code : HC-U6000
Somatic Genetic Testing Market Overview: FutureWise Market Research has instantiated a report that provides an intricate analysis of Somatic Genetic Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Somatic Genetic Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Somatic Genetic Testing Market: • Agilent Technologies, Inc. • ARUP Laboratories • ASURAGEN Inc. • Beijing Genomics Institute (BGI) Genomics Co., Ltd • bioMerieux S.A. • CENTOGENE N.V. • CIRCULOGENE Theranostics, LLC • F. Hoffmann-La Roche Ltd. • Guardant Health, Inc. • Illumina, Inc. • Invivoscribe, Inc. • Laboratory Corporation of America Holdings • Mission Bio • NeoGenomics Laboratories, Inc. • OmniSeq • Oxford Nanopore Technologies Ltd. • Pacific Biosciences of California, Inc. • QIAGEN N.V. • Quest Diagnostics Incorporated • Thermo Fisher Scientific Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) Somatic Genetic Testing Market Segmentation: By Product Type • Products o Kits and Assays o Instruments o Software • Services By Sample • Tissue-Based • Blood-Based • Bone Marrow Aspirates • Others By Technology • Sequencing o Next-Generation Sequencing (NGS) o Sequencing by Synthesis o Other Next-Generation Sequencing Technologies o Traditional Sequencing • Polymerase Chain Reaction o Real-Time Polymerase Chain Reaction (RT-PCR) o Digital Polymerase Chain Reaction (dPCR) • Microarray • Other Technologies By Application • Solid Tumors o Breast Cancer o Prostate Cancer o Colorectal Cancer o Lung Cancer o Liver Cancer o Ovarian Cancer o Other Solid Tumors • Hematological Malignancies o Leukemia o Lymphoma o Myeloma By End User • Academic and Research Institutions • Hospitals and Diagnostic Laboratories • Pharmaceutical and Biotechnology Companies • Contract Research Organizations • Other By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Somatic Genetic Testing Market By Product Type, By Sample, By Technology, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Somatic Genetic Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Somatic Genetic Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Somatic Genetic Testing Market: • Agilent Technologies, Inc. • ARUP Laboratories • ASURAGEN Inc. • Beijing Genomics Institute (BGI) Genomics Co., Ltd • bioMerieux S.A. • CENTOGENE N.V. • CIRCULOGENE Theranostics, LLC • F. Hoffmann-La Roche Ltd. • Guardant Health, Inc. • Illumina, Inc. • Invivoscribe, Inc. • Laboratory Corporation of America Holdings • Mission Bio • NeoGenomics Laboratories, Inc. • OmniSeq • Oxford Nanopore Technologies Ltd. • Pacific Biosciences of California, Inc. • QIAGEN N.V. • Quest Diagnostics Incorporated • Thermo Fisher Scientific Inc. (Note: The list of the major players will be updated with the latest market scenario and trends)
Somatic Genetic Testing Market Segmentation: By Product Type • Products o Kits and Assays o Instruments o Software • Services By Sample • Tissue-Based • Blood-Based • Bone Marrow Aspirates • Others By Technology • Sequencing o Next-Generation Sequencing (NGS) o Sequencing by Synthesis o Other Next-Generation Sequencing Technologies o Traditional Sequencing • Polymerase Chain Reaction o Real-Time Polymerase Chain Reaction (RT-PCR) o Digital Polymerase Chain Reaction (dPCR) • Microarray • Other Technologies By Application • Solid Tumors o Breast Cancer o Prostate Cancer o Colorectal Cancer o Lung Cancer o Liver Cancer o Ovarian Cancer o Other Solid Tumors • Hematological Malignancies o Leukemia o Lymphoma o Myeloma By End User • Academic and Research Institutions • Hospitals and Diagnostic Laboratories • Pharmaceutical and Biotechnology Companies • Contract Research Organizations • Other By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Somatic Genetic Testing Market By Product Type, By Sample, By Technology, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Somatic Genetic Testing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Somatic Genetic Testing Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Somatic Genetic Testing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Somatic Genetic Testing Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Products 7.1.1. Kits and Assays 7.1.2. Instruments 7.1.3. Software 7.4. Services 8. Global Somatic Genetic Testing Market, By Sample Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Tissue-Based 8.2. Blood-Based 8.3. Bone Marrow Aspirates 8.4. Others 9. Global Somatic Genetic Testing Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Sequencing 9.1.1. Next-Generation Sequencing (NGS) 9.1.1.1. Sequencing by Synthesis 9.1.1.2. Other Next-Generation Sequencing Technologies 9.1.2. Traditional Sequencing 9.2. Polymerase Chain Reaction 9.2.1. Real-Time Polymerase Chain Reaction (RT-PCR) 9.2.2. Digital Polymerase Chain Reaction (dPCR) 9.3. Microarray 9.4. Other Technologies 10. Global Somatic Genetic Testing Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Solid Tumors 10.1.1. Breast Cancer 10.1.2. Prostate Cancer 10.1.3. Colorectal Cancer 10.1.4. Lung Cancer 10.1.5. Liver Cancer 10.1.6. Ovarian Cancer 10.1.7. Other Solid Tumors 10.2. Hematological Malignancies 10.2.1. Leukemia 10.2.2. Lymphoma 10.2.3. Myeloma 11. Global Somatic Genetic Testing Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Academic and Research Institutions 11.2. Hospitals and Diagnostic Laboratories 11.3. Pharmaceutical and Biotechnology Companies 11.4. Contract Research Organizations 11.5. Other 12. North America Somatic Genetic Testing Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027 13. Latin America Somatic Genetic Testing Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Brazil 13.2.2. Venezuela 13.2.3. Argentina 13.2.4. Rest of Latin America 13.3. Market Size (USD Million) Forecast for Latin America 2020-2027 14. Europe Somatic Genetic Testing Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Rest of Europe 14.3. Market Size (USD Million) Forecast for Europe 2020-2027 15. Asia Pacific Somatic Genetic Testing Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. India 15.2.4. Australia and New Zealand 15.2.5. ASEAN 15.2.6. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027 17. Market Share Analysis and Competitive Landscape 17.1. Global Landscape - Key Players, Revenue and Presence 17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 17.3. Global Emerging Companies 17.4. North America - Market Share Analysis and Key Regional Players 17.5. Europe - Market Share Analysis and Key Regional Players 17.6. Asia Pacific - Market Share Analysis and Key Regional Players 17.7. Global Key Player - Growth Matrix 18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 18.1. Agilent Technologies, Inc. 18.1.1. Company Overview 18.1.2. Product Portfolio 18.1.3. SWOT Analysis 18.1.4. Financial Overview 18.1.5. Strategic Overview 18.2. ARUP Laboratories 18.2.1. Company Overview 18.2.2. Product Portfolio 18.2.3. SWOT Analysis 18.2.4. Financial Overview 18.2.5. Strategic Overview 18.3. ASURAGEN Inc. 18.3.1. Company Overview 18.3.2. Product Portfolio 18.3.3. SWOT Analysis 18.3.4. Financial Overview 18.3.5. Strategic Overview 18.4. Beijing Genomics Institute (BGI) Genomics Co., Ltd 18.4.1. Company Overview 18.4.2. Product Portfolio 18.4.3. SWOT Analysis 18.4.4. Financial Overview 18.4.5. Strategic Overview 18.5. bioMerieux S.A. 18.5.1. Company Overview 18.5.2. Product Portfolio 18.5.3. SWOT Analysis 18.5.4. Financial Overview 18.5.5. Strategic Overview 18.6. CENTOGENE N.V. 18.6.1. Company Overview 18.6.2. Product Portfolio 18.6.3. SWOT Analysis 18.6.4. Financial Overview 18.6.5. Strategic Overview 18.7. CIRCULOGENE Theranostics, LLC 18.7.1. Company Overview 18.7.2. Product Portfolio 18.7.3. SWOT Analysis 18.7.4. Financial Overview 18.7.5. Strategic Overview 18.8. F. Hoffmann-La Roche Ltd. 18.8.1. Company Overview 18.8.2. Product Portfolio 18.8.3. SWOT Analysis 18.8.4. Financial Overview 18.8.5. Strategic Overview 18.9. Guardant Health, Inc. 18.9.1. Company Overview 18.9.2. Product Portfolio 18.9.3. SWOT Analysis 18.9.4. Financial Overview 18.9.5. Strategic Overview 18.10. Illumina, Inc. 18.10.1. Company Overview 18.10.2. Product Portfolio 18.10.3. SWOT Analysis 18.10.4. Financial Overview 18.10.5. Strategic Overview 18.11. Invivoscribe, Inc. 18.11.1. Company Overview 18.11.2. Product Portfolio 18.11.3. SWOT Analysis 18.11.4. Financial Overview 18.11.5. Strategic Overview 18.12. Laboratory Corporation of America Holdings 18.12.1. Company Overview 18.12.2. Product Portfolio 18.12.3. SWOT Analysis 18.12.4. Financial Overview 18.12.5. Strategic Overview 18.13. Mission Bio 18.13.1. Company Overview 18.13.2. Product Portfolio 18.13.3. SWOT Analysis 18.13.4. Financial Overview 18.13.5. Strategic Overview 18.14. NeoGenomics Laboratories, Inc. 18.14.1. Company Overview 18.14.2. Product Portfolio 18.14.3. SWOT Analysis 18.14.4. Financial Overview 18.14.5. Strategic Overview 18.15. OmniSeq 18.15.1. Company Overview 18.15.2. Product Portfolio 18.15.3. SWOT Analysis 18.15.4. Financial Overview 18.15.5. Strategic Overview 18.16. Oxford Nanopore Technologies Ltd. 18.16.1. Company Overview 18.16.2. Product Portfolio 18.16.3. SWOT Analysis 18.16.4. Financial Overview 18.16.5. Strategic Overview 18.17. Pacific Biosciences of California, Inc. 18.17.1. Company Overview 18.17.2. Product Portfolio 18.17.3. SWOT Analysis 18.17.4. Financial Overview 18.17.5. Strategic Overview 18.18. QIAGEN N.V. 18.18.1. Company Overview 18.18.2. Product Portfolio 18.18.3. SWOT Analysis 18.18.4. Financial Overview 18.18.5. Strategic Overview 18.19. Quest Diagnostics Incorporated 18.19.1. Company Overview 18.19.2. Product Portfolio 18.19.3. SWOT Analysis 18.19.4. Financial Overview 18.19.5. Strategic Overview 18.20. Thermo Fisher Scientific Inc. 18.20.1. Company Overview 18.20.2. Product Portfolio 18.20.3. SWOT Analysis 18.20.4. Financial Overview 18.20.5. Strategic Overview 19. Pre and Post COVID-19 Impact 19.1. Positive influence on the healthcare industry 19.2. The financial disruption of the manufacturing sector 19.3. Impact of COVID-19 on emerging companies 19.4. Significant mandates in the healthcare regulations initiated by administrations 19.5. The overall economic slowdown of the developing and developed nations 20. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics